S&P 500   4,387.25 (-0.52%)
DOW   34,410.84 (+0.13%)
QQQ   347.16 (-1.74%)
AAPL   160.06 (-0.97%)
MSFT   291.60 (-1.61%)
FB   303.62 (-1.65%)
GOOGL   2,569.53 (-1.78%)
AMZN   2,814.29 (-2.65%)
TSLA   924.88 (-0.55%)
NVDA   225.43 (-3.55%)
BABA   119.04 (-1.10%)
NIO   24.00 (-3.50%)
AMD   112.31 (-3.62%)
CGC   7.33 (-0.95%)
MU   81.51 (-1.74%)
GE   90.90 (-6.20%)
T   26.34 (+0.00%)
F   19.94 (-2.21%)
DIS   136.21 (-0.91%)
AMC   16.22 (-2.52%)
PFE   52.67 (+2.19%)
ACB   4.19 (-3.01%)
BA   202.94 (-0.62%)
S&P 500   4,387.25 (-0.52%)
DOW   34,410.84 (+0.13%)
QQQ   347.16 (-1.74%)
AAPL   160.06 (-0.97%)
MSFT   291.60 (-1.61%)
FB   303.62 (-1.65%)
GOOGL   2,569.53 (-1.78%)
AMZN   2,814.29 (-2.65%)
TSLA   924.88 (-0.55%)
NVDA   225.43 (-3.55%)
BABA   119.04 (-1.10%)
NIO   24.00 (-3.50%)
AMD   112.31 (-3.62%)
CGC   7.33 (-0.95%)
MU   81.51 (-1.74%)
GE   90.90 (-6.20%)
T   26.34 (+0.00%)
F   19.94 (-2.21%)
DIS   136.21 (-0.91%)
AMC   16.22 (-2.52%)
PFE   52.67 (+2.19%)
ACB   4.19 (-3.01%)
BA   202.94 (-0.62%)
S&P 500   4,387.25 (-0.52%)
DOW   34,410.84 (+0.13%)
QQQ   347.16 (-1.74%)
AAPL   160.06 (-0.97%)
MSFT   291.60 (-1.61%)
FB   303.62 (-1.65%)
GOOGL   2,569.53 (-1.78%)
AMZN   2,814.29 (-2.65%)
TSLA   924.88 (-0.55%)
NVDA   225.43 (-3.55%)
BABA   119.04 (-1.10%)
NIO   24.00 (-3.50%)
AMD   112.31 (-3.62%)
CGC   7.33 (-0.95%)
MU   81.51 (-1.74%)
GE   90.90 (-6.20%)
T   26.34 (+0.00%)
F   19.94 (-2.21%)
DIS   136.21 (-0.91%)
AMC   16.22 (-2.52%)
PFE   52.67 (+2.19%)
ACB   4.19 (-3.01%)
BA   202.94 (-0.62%)
S&P 500   4,387.25 (-0.52%)
DOW   34,410.84 (+0.13%)
QQQ   347.16 (-1.74%)
AAPL   160.06 (-0.97%)
MSFT   291.60 (-1.61%)
FB   303.62 (-1.65%)
GOOGL   2,569.53 (-1.78%)
AMZN   2,814.29 (-2.65%)
TSLA   924.88 (-0.55%)
NVDA   225.43 (-3.55%)
BABA   119.04 (-1.10%)
NIO   24.00 (-3.50%)
AMD   112.31 (-3.62%)
CGC   7.33 (-0.95%)
MU   81.51 (-1.74%)
GE   90.90 (-6.20%)
T   26.34 (+0.00%)
F   19.94 (-2.21%)
DIS   136.21 (-0.91%)
AMC   16.22 (-2.52%)
PFE   52.67 (+2.19%)
ACB   4.19 (-3.01%)
BA   202.94 (-0.62%)
NASDAQ:PHAR

Pharming Group Stock Forecast, Price & News

$8.53
+0.77 (+9.92%)
(As of 01/25/2022 10:06 AM ET)
Add
Compare
Today's Range
$8.53
$8.53
50-Day Range
$7.58
$9.45
52-Week Range
$7.58
$14.70
Volume
10 shs
Average Volume
2,295 shs
Market Capitalization
$553.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive PHAR News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.


Pharming Group logo

About Pharming Group

Pharming Group N.V., a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre- eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has development collaboration and license agreement with Novartis. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PHAR
Fax
N/A
Employees
262
Year Founded
N/A

Sales & Book Value

Annual Sales
$212.10 million
Cash Flow
$0.66 per share
Book Value
$2.67 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$553.38 million
Optionable
Not Optionable

Company Calendar

Today
1/25/2022
Next Earnings (Estimated)
3/03/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.04 out of 5 stars

Medical Sector

1260th out of 1,416 stocks

Pharmaceutical Preparations Industry

610th out of 684 stocks

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -












Pharming Group (NASDAQ:PHAR) Frequently Asked Questions

Are investors shorting Pharming Group?

Pharming Group saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 15,000 shares, an increase of 200.0% from the December 15th total of 5,000 shares. Based on an average trading volume of 9,800 shares, the days-to-cover ratio is presently 1.5 days.
View Pharming Group's Short Interest
.

When is Pharming Group's next earnings date?

Pharming Group is scheduled to release its next quarterly earnings announcement on Thursday, March 3rd 2022.
View our earnings forecast for Pharming Group
.

Who are Pharming Group's key executives?

Pharming Group's management team includes the following people:
  • Dr. Sijmen de Vries M.B.A., M.D., MBA, CEO & Exec. Director (Age 62, Pay $1.24M)
  • Dr. Bruno M. L. Giannetti, Consultant (Age 69, Pay $747.21k)
  • Mr. Jeroen Wakkerman, Chief Financial Officer (Age 52)
  • Ms. Mireille Sanders M.Sc., Chief Operations Officer (Age 53)
  • Susanne Embleton, Investor Relations Mang.
  • Mr. Ruud Van Outersterp, Chief Ethics & Compliance Officer
  • Mr. Anurag Relan, Chief Medical Officer (Age 49)
  • Mr. Paul Th. Jansse, VP & Head of Non-US Commercial Operations (Age 52)
  • Mr. Stephen Toor, Chief Commercial Officer & GM of Americas (Age 50)

What is Pharming Group's stock symbol?

Pharming Group trades on the NASDAQ under the ticker symbol "PHAR."

How do I buy shares of Pharming Group?

Shares of PHAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharming Group's stock price today?

One share of PHAR stock can currently be purchased for approximately $8.53.

How much money does Pharming Group make?

Pharming Group has a market capitalization of $553.38 million and generates $212.10 million in revenue each year.

How many employees does Pharming Group have?

Pharming Group employs 262 workers across the globe.

What is Pharming Group's official website?

The official website for Pharming Group is www.pharming.com.

Where are Pharming Group's headquarters?

Pharming Group is headquartered at DARWINWEG 24, LEIDEN P7, 2333 CR.

How can I contact Pharming Group?

Pharming Group's mailing address is DARWINWEG 24, LEIDEN P7, 2333 CR. The company can be reached via phone at 31-0-71-524-7400 or via email at [email protected].


This page was last updated on 1/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.